Malignant Brain Tumors Completed Phase 1 / 2 Trials for Bevacizumab (DB00112)

Also known as: Malignant Brain Tumor

IndicationStatusPhase
DBCOND0050591 (Malignant Brain Tumors)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02052648Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain TumorsTreatment